Future innovations in treating advanced prostate cancer

The Urologic Clinics of North America
Pratik DesaiThomas A Gardner

Abstract

Many novel techniques for the treatment of prostate cancer are being aggressively investigated because prostate cancer is prevalent in the population and the current treatments for advanced prostate cancer are woefully inadequate. Although the current treatment options prolong life, most patients will eventually experience local recurrence or develop advanced disease. A greater understanding of the molecular events underlying cancer has enabled investigators to explore gene therapy approaches that are targeted against these molecular events. This article discusses antiangiogenic therapy, immune based therapy, and gene therapy. Any of these experimental modalities could be developed to replace hormone ablation therapy which causes unpleasant side effects, decreases the quality of life of the patient, and only temporarily controls the disease.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R BortellG S Stein
Sep 30, 1992·Biochemical and Biophysical Research Communications·B I TermanP Böhlen
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D J GoodN P Bouck
Jan 23, 1987·Science·J Folkman, M Klagsbrun
Jan 1, 1987·Nouvelle Revue Française D'hématologie·A Camez, G Tobelem
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J D'AmatoJ Folkman
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T P QuinnL T Williams
Mar 22, 1996·The Journal of Biological Chemistry·E R SchuurD R Henderson
Jun 1, 1996·Nature Medicine·M S O'ReillyJ Folkman
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·C BanerjeeG S Stein
May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Aug 8, 1996·Nature·K GalaktionovD Beach
Sep 1, 1996·Molecular and Cellular Biology·J A ForsytheG L Semenza
Dec 6, 1996·Science·C J Sherr
Feb 1, 1997·Proceedings of the Society for Experimental Biology and Medicine·C P Chiu, C B Harley
Apr 4, 1997·Science·G PanV M Dixit
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·C WeiJ G Frelinger
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·S GatelyG A Soff

❮ Previous
Next ❯

Citations

Oct 17, 2007·Prostate Cancer and Prostatic Diseases·A R YoungerA Haque
Sep 18, 2007·Medical Oncology·Victor ValdespinoPavel Pisa

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.